Table III.
Toxicity Summary for Treated Patients, Liver Tests
| Patient # | Albumin (g/L) | Total Bilirubin (μmol/L) | ALT (U/L) | AST (U/L) | ||||
|---|---|---|---|---|---|---|---|---|
| Week 0 | Week 8 | Week 0 | Week 8 | Week 0 | Week 8 | Week 0 | Week 8 | |
| 001 | 42 | 42 | 14.9 | 19.3 | 16 | 16 | 23 | 27 |
| 002 | 40 | 37 | 9.0 | 13.5 | 23 | 25 | 38 | 60 |
| 007 | 42 | 40 | 5.5 | 5.0 | 59 | 61 | 86 | 70 |
| 009 | 33 | 39 | 19.9 | 18.1 | 10 | 16 | 28 | 28 |
| 011 | 37 | 40 | 11.8 | 11.8 | 47 | 31 | 38 | 35 |
| 013 | 41 | 43 | 14.4 | 13.6 | 13 | 13 | 22 | 22 |
| 015 | 44 | 44 | 29.1 | 30.6 | 34 | 58 | 39 | 33 |
| 017 | 41 | 40 | 11.0 | 11.4 | 14 | 12 | 25 | 20 |
ALT, serum alanine transaminase (SGPT); AST, serum aspartate transaminase (SGOT).